{"id":"clm_7A6976D86AF0","entity":"amgen","predicate":"cash_and_equivalents","value":"9,301,000,000 United States dollar","value_json":{"fp":"Q2","fy":2024,"accn":"0000318154-24-000035","form":"10-Q","filed":"2024-08-07","period":"Q2 FY2024","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2024-06-30","valid_to":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Amgen cash and equivalents: 9,301,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_7A6976D86AF0, https://asof.is/claim/clm_7A6976D86AF0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/0000318154-24-000035-index.htm.","url":"https://asof.is/claim/clm_7A6976D86AF0","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_635D97E40729","supersedes":["clm_85A3377148F1"],"first_seen_at":"2026-11-08T15:38:26.099962+00:00","updated_at":"2026-11-08T15:38:34.205395+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815424000035/0000318154-24-000035-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2024","published_at":"2024-08-07T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-07"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}